ClosedSuppliesEuropeanOnderhandeling zonder bekendmaking

Production and supply of diacetylmorphine

Ministerie van Volksgezondheid, Welzijn en Sport dtv UBR|HIS · Onderhandeling zonder bekendmaking · 1 lots · 223116
Type
Supplies
33600000
Estimated value
Not published
To deadline
Ongoing
Knock-outs
n/a
exclusion grounds
Award basis
Best price-quality ratio
Assess manuallyconfidence low

The Ministry of Health, Welfare and Sport (Directorate for Nutrition, Health Protection and Prevention) has an urgent shortage of diacetylmorphine (the active substance in the Heroin Treatment Regulation) for the period from 15 July to 31 December 2023. The current contract with Di‑AcetylM B.V. expires on 14 July 2023, necessitating an immediate new supplier to ensure the continuity of patient treatment. The procurement is a negotiated procedure without publication, which limits competition but emphasizes the urgency. The new supplier must be capable of guaranteeing full production, quality control, logistics, and delivery within the specified timeframe, and must comply with all relevant pharmaceutical regulations and safety standards. The contracting authority is seeking a party with proven experience in regulated drug production, strong quality management systems, and a robust supply chain. The procedure is aimed at rapid decision-making, with price, quality, and security of supply being the primary criteria.

Supplies · Onderhandeling zonder bekendmaking · European procedure

European
Contract type
Supplies
Onderhandeling zonder bekendmaking
Estimated value
Estimate not published
Submission deadline
Ongoing
Scope
European
European procedure
Lots
1
1 lots
Main CPV code
Location
Den Haag
CharacteristicsCPV 33SuppliesEU tenderdiacetylmorphineheroin treatmentpharmaceutical supply

01What is being requested

The Ministry of Health, Welfare and Sport (Directorate for Nutrition, Health Protection and Prevention) has an urgent shortage of diacetylmorphine (the active substance in the Heroin Treatment Regulation) for the period from 15 July to 31 December 2023. The current contract with Di‑AcetylM B.V. expires on 14 July 2023, necessitating an immediate new supplier to ensure the continuity of patient treatment. The procurement is a negotiated procedure without publication, which limits competition but emphasizes the urgency. The new supplier must be capable of guaranteeing full production, quality control, logistics, and delivery within the specified timeframe, and must comply with all relevant pharmaceutical regulations and safety standards. The contracting authority is seeking a party with proven experience in regulated drug production, strong quality management systems, and a robust supply chain. The procedure is aimed at rapid decision-making, with price, quality, and security of supply being the primary criteria.

The Ministry of Health, Welfare and Sport (Directorate for Nutrition, Health Protection and Prevention) has a potential shortage of raw materials for the production and supply of diacetylmorphine in the period from 15 July 2023 up to and including 31 December 2023. This shortage is urgent because the contract with the current supplier (Di-AcetylM B.V.) expires on 14 July 2023 and the contracting authority requires certainty as soon as possible regarding the production and supply of diacetylmorphine during the 2023 subsidy year of the Heroin Treatment Regulation.

33600000Supplies
1Lot 1

02Exclusion grounds

Exclusion grounds — consult the ESPD
  • No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

03Value in context

Estimate not published

The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.

04Likely competitors

#Likely bidderFitWins
1Medtronic Trading NL B.V.SME8030×
2Boston Scientific Nederland B.V.SME7620×
3Medipoint WMO B.V.SME7115×
4Johnson & Johnson Medical B.V.SME7016×
5Abbott Medical Nederland B.V.SME7016×
6Mediost B.V.SME6914×

05Legal themes that may be relevant here

06Frequently asked questions

What is the reason for this procurement?
There is a potential shortage of raw materials for the production and supply of diacetylmorphine. The current contract with Di-AcetylM B.V. expires on 14 July 2023, necessitating certainty for the continuity of the Heroin Treatment Regulation.
For which period must the supply of diacetylmorphine be guaranteed?
The assignment concerns the production and supply of diacetylmorphine for the period from 15 July 2023 up to and including 31 December 2023.

Automatically compiled from the official tender data and documents.

07Estimated value versus the market

p25
€ 317K
median
€ 892K
p75
€ 3,3 mln
deze opdracht

Gegunde waarden in CPV 33 · leveringen n=528